Wolters Kluwer has completed the sale of its pharma-related marketing and publishing services business to Springer Science+Business Media.
The deal, first announced last July, is part of the Dutch information services group’s strategy to focus on core health markets through its Wolters Kluwer Health & Pharma Solutions division.
“The sale of our pharma-related business will allow us to focus future investments in our core healthcare business in key growth areas such as point of care,” said Nancy McKinstry, the group’s chief executive and chairman of the executive board.
“We are committed to continued investments in innovative solutions that help clinicians around the globe access critical information to improve healthcare.”
The sale represents around 35% of the company's pharma-related assets based on revenue, with Adis and inScience Communications the leading brands, and affects about 450 employees globally.